Showing results (51-60 of 105) with videos related to
Sort By:
Pageof 11
Human Gene Therapy|June 14, 2003
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigenSteven A Rosenberg, James C Yang, Richard M Sherry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJames C Yang, Richard M Sherry, Seth M Steinberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2025
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II StudyShailender Bhatia, Suzanne L Topalian, William Sharfman, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccinesSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.Blood Advances|January 4, 2018
Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapyAmy S Duffield, Maria Libera Ascierto, Robert A Anders, et al.Journal of Translational Medicine|July 6, 2015
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant settingEvan J Lipson, William H Sharfman, Shuming Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4Kimberly E Beck, Joseph A Blansfield, Khoi Q Tran, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigensGiao Q Phan, Christopher E Touloukian, James C Yang, et al.Cancer Immunology Research|August 6, 2016
The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell CarcinomaMaria Libera Ascierto, Tracee L McMiller, Alan E Berger, et al.Cancer Research|January 5, 2013
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D Young, et al.Pageof 11